RHC — Ramsay Health Care Share Price
Last trade - 00:00- AU$14.63bn
- AU$26.26bn
- AU$13.21bn
- 76
- 34
- 91
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 28.11 | ||
| PEG Ratio (f) | 0.6 | ||
| EPS Growth (f) | 88.47% | ||
| Dividend Yield (f) | 2.2% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.59 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 51.16 | ||
| Price to Sales | 1.06 | ||
| EV to EBITDA | 13.97 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.58% | ||
| Return on Equity | 7.26% | ||
| Operating Margin | 6.68% | ||
Financial Summary
| Year End 30th Jun | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 9,180.86 | 11,559.47 | 11,983.4 | 12,442.6 | 13,210.2 | 15,093.66 | 15,914.56 | 8.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -6.62 | +20.58 | -94.1 | n/a | n/a | n/a | +35.09 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ramsay Health Care Limited is an Australia-based healthcare services company. The Company operates through four segments: Asia Pacific, UK, France, and Nordics. Its businesses include Global, Ramsay Australia, Ramsay Sante, Ramsay United Kingdom, Ramsay Sime Darby, and Elysium Healthcare. Its Global business delivers health care services to more than 532 facilities in 10 countries. Ramsay Australia has about 72 private hospitals and day surgery units in Australia. Ramsay Sante is a private care provider in Europe, operating specialist clinics and primary care units in about 350 locations across five countries in Europe. Ramsay United Kingdom has a network of about 34 acute hospitals and day procedure centers. Ramsay Sime Darby operates three hospitals in Indonesia, three hospitals and a nursing college in Malaysia and one day surgery in Hong Kong. Elysium Healthcare provides a range of mental health care in specialist hospitals, residential settings, and community-based homes.
Directors
- Michael Siddle NEC
- Craig McNally CEO
- Martyn Roberts CFO
- Henrietta Rowe GCN
- David Thodey LED
- Steven Sargent NED (60)
- Alison Deans NID (53)
- Claudia Dyckerhoff NID
- James McMurdo NID
- Karen Penrose NID
- Last Annual
- June 30th, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- May 26th, 1975
- Public Since
- September 24th, 1997
- No. of Employees
- 86,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 227,800,000
- Address
- Level 7, Tower B,, 7 Westbourne Street, ST LEONARDS, 2065
- Web
- https://www.ramsayhealth.com/
- Phone
- +61 294333444
- Auditors
- Ernst & Young Australia
Latest News for RHC
Upcoming Events for RHC
Dividend For RHCPA.AX - 2.9337 AUD
Full Year 2023 Ramsay Health Care Ltd Earnings Release
Similar to RHC
Althea group
Australian Stock Exchange - SEATS
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Asian American Medical
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
FAQ
As of Today at 12:19 UTC, shares in Ramsay Health Care are trading at AU$64.23. This share price information is delayed by 15 minutes.
Shares in Ramsay Health Care last closed at AU$64.23 and the price had moved by +1.49% over the past 365 days. In terms of relative price strength the Ramsay Health Care share price has outperformed the ASX All Ordinaries Index by +8.27% over the past year.
The overall consensus recommendation for Ramsay Health Care is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Ramsay Health Care dividend yield is 1.53% based on the trailing twelve month period.
Last year, Ramsay Health Care paid a total dividend of AU$0.99, and it currently has a trailing dividend yield of 1.53%.Looking ahead, the next dividend pay date is 2023-03-30.
We do not have data on when Ramsay Health Care is to next pay dividends. The historic dividend yield on Ramsay Health Care shares is currently 1.53%.
To buy shares in Ramsay Health Care you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$64.23, shares in Ramsay Health Care had a market capitalisation of AU$14.63bn.
Here are the trading details for Ramsay Health Care:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: RHC
Based on an overall assessment of its quality, value and momentum Ramsay Health Care is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ramsay Health Care is AU$69.10. That is 7.59% above the last closing price of AU$64.23.
Analysts covering Ramsay Health Care currently have a consensus Earnings Per Share (EPS) forecast of AU$1.82 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ramsay Health Care. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -1.36%.
As of the last closing price of AU$64.23, shares in Ramsay Health Care were trading -3.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ramsay Health Care PE ratio based on its reported earnings over the past 12 months is 28.11. The shares last closed at AU$64.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ramsay Health Care's management team is headed by:
- Michael Siddle - NEC
- Craig McNally - CEO
- Martyn Roberts - CFO
- Henrietta Rowe - GCN
- David Thodey - LED
- Steven Sargent - NED
- Alison Deans - NID
- Claudia Dyckerhoff - NID
- James McMurdo - NID
- Karen Penrose - NID